The prevalence of atopic dermatitis beyond childhood: A systematic review and meta‐analysis of longitudinal studies
Background There are sparse and conflicting data regarding the long‐term clinical course of atopic dermatitis (AD). Although often described as a childhood disease, newer population‐based estimates suggest the prevalence of pediatric and adult disease may be similar. Methods Our objective was to det...
Saved in:
Published in | Allergy (Copenhagen) Vol. 73; no. 3; pp. 696 - 704 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Denmark
Blackwell Publishing Ltd
01.03.2018
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background
There are sparse and conflicting data regarding the long‐term clinical course of atopic dermatitis (AD). Although often described as a childhood disease, newer population‐based estimates suggest the prevalence of pediatric and adult disease may be similar.
Methods
Our objective was to determine whether there is a decline in the prevalence of AD in population‐based cohorts of patients followed longitudinally beyond childhood. We conducted a systematic review and meta‐analysis including studies assessing AD prevalence across 3 or more points in time. The primary outcome was weighted overall risk difference (percentage decrease in AD prevalence).
Results
Of 2080 references reviewed, 7 studies with 13 515 participants were included. Participants were assessed at 3‐6 time points, ranging from age 3 months to 26 years. The percentage decrease in prevalence after age 12 was 1%, which was not significantly different from zero (95% confidence interval −2%‐5%). Similar results were found with other age cut‐offs.
Conclusion
The prevalence of AD in longitudinal birth cohort studies is similar in childhood and adolescence/early adulthood. |
---|---|
Bibliography: | Funding information This study was supported in part by a training grant from the National Institutes of Health National Center for Advancing Translational Sciences UCSF‐CTSI Grant Number KL2 TR000143 (KA) and by a Wellcome senior research fellowship in clinical science to SML (205039/Z/16/Z). Funding/sponsor was involved in design and conduct of the study: no; collection, management, analysis and interpretation of data: no; preparation review or approval of the manuscript: no; decision to submit the manuscript for publication: no. ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 Edited by: Stephan Weidinger |
ISSN: | 0105-4538 1398-9995 |
DOI: | 10.1111/all.13320 |